BioTime (BTX) Reports Q1 Loss of $0.13/Share

BioTime (NYSE: BTX) reported Q1 EPS of ($0.13), versus ($0.14) reported last year. Revenue for the quarter came in at $1.3 million, versus $1.1 million reported last year.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
• BrainsWay Ltd. (BWAY) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY26 Revenue Guidance